A recent study published in the New England Journal of Medicine found that Wegovy, made by Novo Nordisk, helped teens reduce their BMI by about 16% on average, better than the results in adults
Navigating Use for Non-Diabetics A crucial question frequently arises: Is it okay for non-diabetics to take these medications solely for weight loss
Gastrointestinal safety of semaglutide and tirzepatide vs placebo in obese individuals without diabetes: a systematic review and meta-analysis
In this article, well break down exactly how Ipamorelin and CJC-1295 work, why theyre more effective when stacked, and what to know about dosing, side effects, legality, and more
doi: 10.3389/fnut.2025.1652297 Received 23 June 2025 Accepted 11 July 2025 Published 29 July 2025 Volume 12 - 2025 Edited by Claude Billeaud, Independent Paediatrics Nutrition Expert, Bordeaux, France Reviewed by Nabil Bosco, Lesaffre Group, France Driton Vllasaliu, Kings College London, United Kingdom Updates Copyright 2025 Melnik, Weiskirchen, Weiskirchen, Stremmel, John, Leitzmann and Schmitz
CJC-1295 with DAC produces sustained GHRH-receptor exposure, while CJC-1295 no-DAC (Mod GRF 1-29) produces shorter pulses that more closely resemble the natural pulsatile pattern of GH release